Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This double-blinded, placebo-controlled, randomized trial will compare the effects of the use
of a combined oral contraceptive pill to a placebo pill for women who are experiencing
irregular and/or heavy bleeding associated with the use of an etonogestrel (ETG) implant.
The hypothesis of the study is:
- Use of combined oral contraceptive will significantly improve bleeding patterns for
users of ETG implant
- Continuation rate of ETG implant users will be increased by use of combined oral
contraceptive in women desiring ETG implant removal because of the undesirable bleeding
- Adverse events will be uncommon and acceptable to women who use a combined oral
contraceptive with the ETG implant